The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis
Abstract
Objective: There is substantial evidence supporting the role of interferon (IFN)‐γ–producing T helper (T H ) 1 and interleukin (IL)‐17–expressing T H 17 lymphocytes in multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). However, to date little is known about the potential cooperative interplay between these 2 cytokines. In the current study, we sought to evaluate the frequency of IFN‐γ–expressing T H 17 lymphocytes in MS and EAE, and study their recruitment into the central nervous system (CNS). Methods: Human T H 17 lymphocytes were expanded in vitro from the blood of healthy controls and relapsing MS patients using IL‐23. Immune cell migration to the CNS was assessed in vitro with primary cultures of human blood–brain barrier (BBB)‐derived endothelial cells, and in vivo in EAE mice. Results: We demonstrate that in response to IL‐23, human memory lymphocytes expand into a T H 17 phenotype, with a subpopulation of cells simultaneously expressing IFN‐γ and IL‐17. We note that lymphocytes obtained from the blood of relapsing MS patients have an increased propensity to expand into IFN‐γ–producing T H 17 cells and identify numerous T lymphocytes coexpressing IL‐17 and IFN‐γ in brain tissue of MS patients. We also find lymphocytes expressing both the T H 1‐ and the T H 17‐associated transcription factors RORγt and T‐bet, in situ and in vitro. We further provide in vitro and in vivo evidence that IFN‐γ + T H 17 lymphocytes preferentially cross the human BBB and accumulate in the CNS of mice during the effector phase of EAE. Interpretation: Our data underscore the involvement of IFN‐γ + T H 17 lymphocytes in the pathology of MS and EAE and their preferential recruitment into the CNS during inflammatory events. Ann Neurol 2009;66:390–402
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, some studies show a protective function for IL-17A in colitis [128, 129], possibly due to the role of IL-17A in promoting intestinal epithelial barrier integrity [130].”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [128]
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 557
Lee, Y., Lee, S., & Kim, W. (2024) · Immune Network · doi:10.4110/in.2024.24.e10 · Cited by 25
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis
Martinez, N. E., Sato, F., Kawai, E., Omura, S., Takahashi, S., Yoh, K., & Tsunoda, I. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.07.008 · Cited by 25
Badawi, A. H., & Siahaan, T. J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.07.009 · Cited by 25
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis
Khaiboullina, S. F., Gumerova, A. R., Khafizova, I. F., Martynova, E. V., Lombardi, V. C., Bellusci, S., & Rizvanov, A. A. (2015) · BioMed Research International · doi:10.1155/2015/189638 · Cited by 24
Adult Onset Still's Disease and Autoinflammation
Efthimiou, P., Moorthy, L. N., Mavragani, C. P., Skokos, D., & Fautrel, B. (2012) · International Journal of Inflammation · doi:10.1155/2012/964751 · Cited by 24
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis
Martinez, N. E., Sato, F., Omura, S., Kawai, E., Takahashi, S., Yoh, K., & Tsunoda, I. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.006 · Cited by 24
Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis
Blair, T. C., Manoharan, M., Rawlings-Rhea, S. D., Tagge, I., Kohama, S. G., Hollister‐Smith, J. A., Ferguson, B. M., Woltjer, R. L., Frederick, M. C., Pollaro, J., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.026 · Cited by 25
Activity of T-helper cells in patients with primary Sjogren's syndrome.
Sudzius, G., Mieliauskaitė, D., Butrimienė, İ., Šiaurys, A., Mackiewicz, Z., & Dumalakienė, I. (2013) · PubMed · Cited by 24
Central inflammation versus peripheral regulation in multiple sclerosis
Edwards, L. J., Sharrack, B., Ismail, A., Tumani, H., & Constantinescu, C. S. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5973-5 · Cited by 24
Dysregulated T cells in multiple sclerosis
Chihara, N. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12438 · Cited by 23
Jamann, H., Cui, Q., Desu, H. L., Pernin, F., Tastet, O., Halaweh, A., Farzam‐kia, N., Mamane, V. H., Ouédraogo, O., Cleret‐Buhot, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.850616 · Cited by 24
Self-citationDissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets
Guo, M. H., Sama, P., LaBarre, B. A., Lokhande, H. A., Balibalos, J., Chu, C., Du, X., Kheradpour, P., Kim, C. C., Oniskey, T. K., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02694-y · Cited by 23
Neuroinflammation: Extinguishing a blaze of T cells
Benallegue, N., Kébir, H., & Alvarez, J. I. (2022) · Immunological Reviews · doi:10.1111/imr.13122 · Cited by 25
Self-citationLaquinimod enhances central nervous system barrier functions
Lühder, F., Kébir, H., Odoardi, F., Litke, T., Sonneck, M., Alvarez, J. I., Winchenbach, J., Eckert, N., Hayardeny, L., Sorani, E., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.002 · Cited by 23
Self-citationJohnson, K. P. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003752715 · Cited by 23
Human IL-21+IFN-γ+CD4+ T cells in nasal polyps are regulated by IL-12
Xiao, L., Jia, L., Zhang, Y., Yu, S., Wu, X., Yang, B., Li, H., & Wu, C. Y. (2015) · Scientific Reports · doi:10.1038/srep12781 · Cited by 22
Nitsch, L., Zimmermann, J., Krauthausen, M., Hofer, M. J., Saggu, R., Petzold, G. C., Heneka, M. T., Getts, D. R., Becker, A. J., Campbell, I. L., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1640-0 · Cited by 21
Thomas, O. G., & Olsson, T. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1304281 · Cited by 24
Kaufhold, C. J., Mani, K. K., Akbari, Z., & Sohrabji, F. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.026 · Cited by 21
Dankers, W., den Braanker, H., Paulissen, S. M. J., van Hamburg, J. P., Davelaar, N., Colin, E. M., & Lubberts, E. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02532-9 · Cited by 23
The autoimmune concept of multiple sclerosis
Nicol, B., Salou, M., Laplaud, D. A., & Wekerle, H. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.02.009 · Cited by 23
Barin, J. G., Talor, M. V., Schaub, J. A., Diny, N. L., Hou, X., Hoyer, M., Archer, N. K., Gebremariam, E., Davis, M. F., Miller, L. S., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.07.001 · Cited by 22
Kono, M., Oda, T., Tawada, M., Imada, T., Banno, Y., Taya, N., Kawamoto, T., Tokuhara, H., Tomata, Y., Ishii, N., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.12.008 · Cited by 21
Abarca‐Zabalía, J., García, M. I., Ros, A. L., Marín‐Jiménez, I., Martínez‐Ginés, M. L., López-Cauce, B., Martin-Barbero, M. L., Salvador‐Martín, S., Sanjurjo‐Sáez, M., García‐Domínguez, J. M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020676 · Cited by 21
Nordberg, M., Forsberg, P., Johansson, A., Nyman, D., Jansson, C. C., Ernerudh, J., & Ekerfelt, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.028 · Cited by 21
The IL‐27/IL‐27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients
Clénet, M., Laurent, C., Lemaître, F., Farzam‐kia, N., Tastet, O., Devergne, O., Lahav, B., Girard, M., Duquette, P., Prat, A., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1262 · Cited by 20
Self-citationFatty Acid Metabolism and T Cells in Multiple Sclerosis
Pompura, S. L., Hafler, D. A., & Dominguez‐Villar, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869197 · Cited by 23
Mohammadinasr, M., Montazersaheb, S., Hosseini, V., Kahroba, H., Talebi, M., Molavi, O., Ayromlou, H., & Hejazi, M. S. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156624 · Cited by 20
Transcription Factors and Th17 Cell Development in Experimental Autoimmune Encephalomyelitis
Chen, G., & Shannon, M. F. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006959 · Cited by 20
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment
Bühler, U., Fleischer, V., Luessi, F., Rezk, A., Belikan, P., Graetz, C., Gollan, R., Wolf, C., Lutz, J., Bar‐Or, A., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516658559 · Cited by 20
Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis
Kostić, M. S., Živković, N., Cvetanović, A., & Stojanović, I. R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.002 · Cited by 21
Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation
Liu, C., Wang, H.-C., Yu, S., Jin, R., Tang, H., Liu, Y.-F., Ge, Q., Sun, X.-H., & Zhang, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302554 · Cited by 20
Álvarez‐Sánchez, N., & Dunn, S. E. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_324 · Cited by 21
Soldati, S. G., Bär, A., Vladymyrov, M., Glavin, D., McGrath, J. L., Gosselet, F., Nishihara, H., Goelz, S. E., & Engelhardt, B. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02797-8 · Cited by 23
Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists
Sun, N., Huang, Y., Yu, M., Zhao, Y., Chen, J., Zhu, C., Song, M., Guo, H., Xie, Q., & Wang, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112536 · Cited by 19
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
Hasheminia, S. J., Tolouei, S., Zarkesh‐Esfahani, S. H., Shaygannejad, V., Shirzad, H. A., Torabi, R., & Chaloshtory, M. H. Z. (2015) · PubMed · Cited by 19
Alvarenga-Filho, H., Salles, M., Hygino, J., Ferreira, T. B., Sacramento, P. M., Monteiro, C., Vasconcelos, C., Alvarenga, R., & Bento, C. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.12.013 · Cited by 20
Kroth, J., Ciolac, D., Fleischer, V., Koirala, N., Krämer, J., Muthuraman, M., Luessi, F., Bittner, S., González‐Escamilla, G., Zipp, F., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517748474 · Cited by 19
The role of IL-23/IL-17 axis in ischemic stroke from the perspective of gut-brain axis
Jiang, Y., Dai, Y., Liu, Z., Liao, Y., Sun, S., Kong, X., Hu, J., & Tang, Y. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109505 · Cited by 18
IFN-β differentially regulates the function of T cell subsets in MS and EAE
Kavrochorianou, N., Markogiannaki, M., & Haralambous, S. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.013 · Cited by 18
Collins, F., Kazmi, M. A., & Muraro, P. A. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1297232 · Cited by 18
Malt1 inactivation attenuates experimental colitis through the regulation of Th17 and Th1/17 cells
Nakamura, Y., Igaki, K., Komoike, Y., Yokoyama, K., & Tsuchimori, N. (2018) · Inflammation Research · doi:10.1007/s00011-018-1207-y · Cited by 19
Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice
Frank, K., Abeynaike, S. A., Nikzad, R., Patel, R. R., Roberts, A. J., Roberto, M., & Paust, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239246 · Cited by 18
The immune system in neurological diseases: what innate‐like T cells have to say
Wyatt-Johnson, S. K., Afify, R., & Brutkiewicz, R. R. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.02.003 · Cited by 17
Frers, R. A. K., Losada, M. E. O., Kobiec, T., Udovin, L., Bertolino, M. L. A., Herrera, M. I., & Capani, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912005 · Cited by 17
Delgado‐Arévalo, C., Calvet‐Mirabent, M., Triguero‐Martínez, A., Vázquez, E., Benguría, A., Largo, R., Calzada‐Fraile, D., Popova, O., Sánchez‐Cerrillo, I., Tsukalov, I., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.152886 · Cited by 18
Igaki, K., Nakamura, Y., Tanaka, M., Mizuno, S., Yoshimatsu, Y., Komoike, Y., Uga, K., Shibata, A., Imaichi, H., Takayuki, S., et al. (2019) · Inflammation Research · doi:10.1007/s00011-019-01234-y · Cited by 17
Horellou, P., de Chalus, A., Giorgi, L., Leroy, C., Chrétien, P., Hacein‐Bey‐Abina, S., Bourgeois, C., Xavier Mariette, A., Serguera, C., Grand, R. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.679770 · Cited by 20
Regulation of lymphocyte trafficking in central nervous system autoimmunity
Oukka, M., & Bettelli, E. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.008 · Cited by 19
ALCAM on human oligodendrocytes mediates CD4 T cell adhesion
Jamann, H., Desu, H. L., Cui, Q., Halaweh, A., Tastet, O., Klément, W., Zandee, S., Pernin, F., Mamane, V. H., Ouédraogo, O., et al. (2023) · Brain · doi:10.1093/brain/awad286 · Cited by 16
Self-citationWang, H., Lee, T., & Lin, C. (2011) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2011.01.002 · Cited by 16
ssICAM-1, IL-21 and IL-23 in patients with tick borne encephalitis and neuroborreliosis
Moniuszko-Malinowska, A. M., Pancewicz, S. A., Czupryna, P., Grygorczuk, S., Świerzbińska, R., Kondrusik, M., Penza, P., & Zajkowska, J. M. (2012) · Cytokine · doi:10.1016/j.cyto.2012.05.007 · Cited by 16
Overexpression of RORγt Enhances Pulmonary Inflammation after Infection with Mycobacterium Avium
Matsuyama, M., Ishii, Y., Sakurai, H., Ano, S., Morishima, Y., Yoh, K., Takahashi, S., Ogawa, K., & Hizawa, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147064 · Cited by 16
CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis
Fournier, A. P., Zandee, S., Charabati, M., Peelen, E., Tastet, O., Alvarez, J. I., Kébir, H., Bourbonnière, L., Larouche, S., Lahav, B., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200022 · Cited by 15
Self-citationTh17 cell promotes apoptosis of IL-23R+ neurons in experimental autoimmune encephalomyelitis
Sonar, S. A., Meitei, H. T., Karmakar, S., Mishra, A., Inamdar, S., Lenka, N., & Lal, G. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.109898 · Cited by 15
Zhao, Y., Zhang, X., Ding, Z., Yang, X., Zhang, H., Yu, J., Li, Y., Liu, C., Zhang, Q., Zhang, H., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0411-7 · Cited by 15
Targeting pathogenic T helper cell memory
Chang, H., & Radbruch, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140954 · Cited by 15
Quirant‐Sánchez, B., Presas‐Rodríguez, S., Mansilla, M. J., Teniente‐Serra, A., Hervás, J. V., Brieva, L., Torres, E. M., Cano, A., Munteis, E., Navarro‐Barriuso, J., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/8147803 · Cited by 15
Anchan, A., Martin, O., Hucklesby, J. J. W., Finlay, G. J., Johnson, R. H., Robilliard, L. D., O’Carroll, S. J., Angel, C. E., & Graham, E. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218193 · Cited by 15
Li, X., Cheng, W., Zhang, J., Li, D., Fei, W., & Cui, N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.950188 · Cited by 14
Gonczi, C. M. C., Hajiaghayi, M., Gholizadeh, F., Soares, M. A. X., Touma, F., Naranjo, C. L., Rios, A. J., Pozzebon, C., Daigneault, T., Burchell-Reyes, K., et al. (2023) · Human Immunology · doi:10.1016/j.humimm.2023.06.007 · Cited by 14
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Alasmari, A. F., Shahid, M., Al‐Mazroua, H. A., Alomar, H. A., AsSobeai, H. M., Alshamrani, A. A., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176086 · Cited by 15
Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells
Pennell, L. M., & Fish, E. N. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0088 · Cited by 14
Posová, H., Horáková, D., Čapek, V., Uher, T., Hrušková, Z., & Havrdová, E. (2017) · BMC Neurology · doi:10.1186/s12883-017-0915-1 · Cited by 14
Patterson, A. R., Bolcas, P. E., Lampe, K., Cantrell, R., Ruff, B. P., Lewkowich, I. P., Hogan, S. P., Janssen, E. M., Bleesing, J., Hershey, G. K. K., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.018 · Cited by 14
Fadlallah, S. M., Hussein, H. M., Jallad, M.-A., Shehab, M., Jurjus, A. R., Matar, G. M., & Rahal, E. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672752 · Cited by 14
Smith, K. J., Minns, D., McHugh, B. J., Holloway, R. K., O’Connor, R. A., Williams, A., Melrose, L. A., McPherson, R. C., Miron, V. E., Davidson, D. J., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001554 · Cited by 20
Igaki, K., Nakamura, Y., Komoike, Y., Uga, K., Shibata, A., Ishimura, Y., Yamasaki, M., Tsukimi, Y., & Tsuchimori, N. (2018) · Inflammation · doi:10.1007/s10753-018-0875-7 · Cited by 14
Kersh, A. E., Edwards, L. J., & Evavold, B. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401456 · Cited by 13
Guo, W., Wang, C., Wang, X., Luo, C., Yu, D.-M., Wang, Y.-H., Chen, Y., Lei, W., Gao, X.-D., & Yao, W. (2015) · OncoTarget · doi:10.18632/oncotarget.5164 · Cited by 14
Kearns, P. K. A., Casey, H., & Leach, J. P. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.06.014 · Cited by 13
Almulla, A., Jaleel, A. K. A., Algon, A. A. A., Tunvirachaisakul, C., Hassoun, H., Al-hakeim, H., & Maes, M. (2022) · medRxiv · doi:10.3390/brainsci13071073 · Cited by 10
Shimizu, J., Kaneko, F., & Suzuki, N. (2013) · Genetics Research International · doi:10.1155/2013/363859 · Cited by 15
Matrine Mediated Immune Protection in MS by Regulating Gut Microbiota and Production of SCFAs
Dou, M., Chu, Y., Zhou, X., Wang, M., Li, X., Ma, R., Fan, Z., Zhao, X., Wang, W., Li, S., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03568-5 · Cited by 12
Ky, M. N., Duran, A., Hasantari, I., Bru, A., Deloire, M., Brochet, B., Ruet, A., & Schmitt, N. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200166 · Cited by 13
Dou, M., Zhou, X., Li, L., Zhang, M., Wang, W., Wang, M., Jing, Y., Ma, R., Zhao, J., & Zhu, L. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640778 · Cited by 13
Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells
Lee, J., Koo, S.-Y., Nam, H., Lee, J.-B., Ko, J., Kim, K. M., Park, E., Kim, T. J., Lee, H., Go, H., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00671-2 · Cited by 12
Distinct Immunological Features of Inflammatory Demyelinating Diseases of the Central Nervous System
Chen, B., Gui, M., Ji, S., Xie, Y., Tian, D., & Bu, B. (2021) · NeuroImmunoModulation · doi:10.1159/000519835 · Cited by 12
Rolla, S., Mercanti, S. F. D., Bardina, V., Maglione, A., Taverna, D., Novelli, F., Cocco, E. E., Vladić, A., Habek, M., Adamec, I., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.818325 · Cited by 12
Fazazi, M. R., Ruda, G. F., Brennan, P. E., & Rangachari, M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110748 · Cited by 13
Is T-bet a Potential Therapeutic Target in Multiple Sclerosis?
Racke, M., Yang, Y.-H., & Lovett-Racke, A. (2014) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.2014.0020 · Cited by 12
Nash, Y., Ganoth, A., Borenstein‐Auerbach, N., Levy‐Barazany, H., Goldsmith, G., Kopelevich, A., Pozyuchenko, K., Sakhneny, L., Lazdon, E., Blanga‐Kanfi, S., et al. (2021) · The FASEB Journal · doi:10.1096/fj.201901945r · Cited by 12
Capone, A., Naro, C., Bianco, M., Bardi, M. D., Noël, F., Macchi, P., Battistini, L., Soumelis, V., Volpe, E., & Sette, C. (2021) · iScience · doi:10.1016/j.isci.2021.102492 · Cited by 12
Tsai, K.-H., Tsai, F., Lin, H.-J., Lin, H.-J., Liu, Y.-H., Liao, W., & Wan, L. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-116 · Cited by 11
Shafiei, M., & Mozhgani, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03303-0 · Cited by 12
Yazdani, M., Khosropanah, S., & Doroudchi, M. (2019) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2019.87525 · Cited by 11
Jamshidian, A., Abd‐Nikfarjam, B., Khademi, Z., Shaygannejad, V., & Salehi, M. (2020) · Journal of Clinical Apheresis · doi:10.1002/jca.21755 · Cited by 11
Regulation of Autoreactive CD4 T Cells by FoxO1 Signaling in CNS Autoimmunity
Kraus, E. E., Kakuk‐Atkins, L., Farinas, M. F., Jeffers, M., Lovett‐Racke, A. E., & Yang, Y. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577675 · Cited by 13
Single-cell analysis of the human immune system reveals sex-specific dynamics of immunosenescence
Sopena-Rios, M., Ripoll-Cladellas, A., Omidi, F., Ballouz, S., Alquicira-Hernández, J., Oelen, R., Hewitt, A. W., Franke, L., van der Wijst, M. G. P., Powell, J. E., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01099-x · Cited by 13
Horellou, P., Flet‐Berliac, L., Leroy, C., Giorgi, L., Joly, C., Desjardins, D., Chrétien, P., Hacein‐Bey‐Abina, S., Grand, R. L., & Deiva, K. (2023) · Brain Communications · doi:10.1093/braincomms/fcad063 · Cited by 10
Restriction of innate Tγδ17 cell plasticity by an AP-1 regulatory axis
Parker, M. E., Mehta, N. U., Liao, T.-C., Tomaszewski, W. H., Snyder, S., Busch, J., & Ciofani, M. (2025) · Nature Immunology · doi:10.1038/s41590-025-02206-7 · Cited by 12
Kurschus, F. C., Wörtge, S., & Waisman, A. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387663-8.00001-6 · Cited by 10
Li, M., Hamilton, R., Salapa, H. E., & Levin, M. C. (2021) · Brain Sciences · doi:10.3390/brainsci11101282 · Cited by 10
Lu, B., Liu, D., Gui, B., Gou, J., Dong, H., Hu, Q., Feng, J., Mao, Y., Shen, X., Wang, S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00828 · Cited by 10
Xie, L., Lv, J., Saimaier, K., Han, S., Han, M., Wang, C., Liu, G., Zhuang, W., Jiang, X., & Du, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110787 · Cited by 10
The immunology of multiple sclerosis
Bar‐Or, A., & Darlington, P. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.006 · Cited by 10
Tang, Z., Shi, J., Xu, S., Liu, S., Yin, W., Xiang, Y., Li, J., He, Z., Yao, X., Zhou, L., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011959 · Cited by 10
Meitei, H. T., Kulkarni, N., Shirolkar, A. R., Rapole, S., Sharma, P., Mujeeb, V. R., Srivastava, S., & Lal, G. (2025) · iScience · doi:10.1016/j.isci.2025.114385 · Cited by 8
The Blood–Brain Barrier in Neuroinflammation
Shimizu, F., & Kanda, T. (2013) · Advances in neurobiology · doi:10.1007/978-1-4614-8313-7_10 · Cited by 9
Tănăsescu, R., Frakich, N., Chou, I., Filippini, P., Podda, G., Xin, G., Muraleedharan, R., Jerca, O. P., Onion, D., & Constantinescu, C. S. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00539-9 · Cited by 10
Metadata
- Authors
- Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A.
- Affiliations
- Hôpital Notre-Dame (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 66
- Issue
- 3
- Pages
- 390-402
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2127568644
- Cited by
- 551
- References
- 39
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 20 · 2023: 36 · 2022: 34 · 2021: 38 · 2020: 27 · 2019: 35 · 2018: 34 · 2017: 40 · 2016: 37 · 2015: 47 · 2014: 42 · 2013: 36 · 2012: 29
- FWCI
- 22.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- multiple sclerosis, experimental autoimmune encephalomyelitis, Th17 cells, interferon-gamma, IL-17, IL-23, blood-brain barrier, T-bet, memory T cells, relapsing multiple sclerosis
- MeSH terms
- Adult, Animals, Blood-Brain Barrier, Brain, Cell Migration Inhibition, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Humans, Interferon-gamma, Mice, Inbred C57BL, Middle Aged, Multiple Sclerosis, T-Lymphocytes, Th1 Cells, Th2 Cells, Interleukin-17, Multiple Sclerosis, Relapsing-Remitting, Mice, Interleukin-23, Cell Migration Assays, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review